I attended the Iowa Board of Pharmacy’s meeting on Wednesday, November 4, 2015, because I noticed that the recommendation for the reclassification of cannabidiol that the board approved on January 5, 2015, was not on the list of proposed changes to the schedules of controlled substances for 2016. That item was on the agenda for 11:00 a.m., so I took a couple hours of vacation and attended the meeting. Just to be cautious, I filed a written comment on the item asking why cannabidiol was not included.
And, true to form, the chair of the board, Jim Miller, took an exceptionally long time with a presentation on telepharmacy that he was none too pleased with. The discussion on the list of proposed changes to the schedules was delayed until 1:00 p.m. and I had to leave.
While I was at the meeting, I noticed that my request for clarification has been placed in front of the assistant attorney general, Meghan Gavin. As I was leaving, I asked Ms. Gavin if I could get a written response to my question. Ms. Gavin said the recommendation to reclassify cannabidiol was only for 2016.
While I was there, I happened to talk with Dale Woolery, Deputy Director of the Office of Drug Control Policy. I asked him what was going on and he said a lot of the stuff the board was recommending for 2016 was stuff that didn’t get enacted in 2015. That did not jive with what Ms. Gavin told me. Just to be sure, I looked at HF 567 which is legislation from 2015 that is still pending in the Iowa House, and, sure enough, some of the same stuff in the board’s 2016 legislative proposal is in HF 567 from 2015.
Ms. Gavin said I was not entitled to a written request and asked me if I wanted my request put on the agenda for the next meeting. I contacted her later and told her my request was a comment on an agenda item and she could do whatever she wanted with it. She said she does not represent the board, but there she was with my request in front of her at the meeting.
So, today I filed an open records request under Iowa Code Chapter 22 asking for any action the board has taken on their January 5, 2015, proposal to reclassify cannabidiol. I’m guessing the board hasn’t lifted a finger to promote their written decision in January. We’ll soon find out. The board has 20 days to respond.